Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $16.53 USD
Change Today +0.02 / 0.12%
Volume 6.5M
As of 8:04 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael F. Mahoney

Chief Executive Officer, President and Director,Boston Scientific Corporation
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Michael F. Mahoney, also known as Mike, has been the Chief Executive Officer of Boston Scientific Corporation since November 1, 2012 and as its President since October 17, 2011. At Boston Scientific Corporation, Mr. Mahoney is responsible for Boston Scientific's Cardiac Rhythm Management (CRM) and Endoscopy (GI and Pulmonary) businesses, as well as certain corporate functions. He joined Boston Scientific in October 2011, having established a track record of more ...

Read Full Background

Corporate Headquarters*

300 Boston Scientific Way
Marlborough, Massachusetts 01752

United States

Phone: 508-683-4000
Fax: --

Board Members Memberships*

Chief Executive Officer, President and Director


University of Iowa
Wake Forest University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$921,302

Stock Options*

Restricted Stock Awards$6,044,228
All Other Compensation$59,866
Exercisable Options502,604
Exercisable Options Value$3,319,851
Unexercisable Options1,178,956
Unexercisable Options Value$5,314,063
Total Value of Options$8,633,913
Total Number of Options1,681,560

Total Compensation*

Total Annual Cash Compensation$2,385,318
Total Short Term Compensation$921,302
Other Long Term Compensation$6,104,094
Total Calculated Compensation$10,527,884
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BSX:US $16.53 USD +0.02


Vincent A. Forlenza Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Becton, Dickinson and Company
David C. Dvorak Chief Executive Officer, President and Director
Zimmer Biomet Holdings, Inc.
Daniel J. Starks Chairman, Chief Executive Officer and President
St. Jude Medical Inc.
Hiroyuki Sasa President and Representative Director
Olympus Corporation
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOSTON SCIENTIFIC CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at